Majesco Entertainment News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.12.22	PolarityTE Announces LOI With Michael Brauser For Acquisition Proposal (RTTNews)
27.12.22	PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company (PR Newswire)
10.11.22	PolarityTE Inc. Q3 Loss Rises (RTTNews)
10.11.22	PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update (PR Newswire)
09.11.22	PolarityTE Confirms Receipt Of Offer From Michael Brauser - Quick Facts (RTTNews)
09.11.22	PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company (PR Newswire)
13.09.22	PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022 (PR Newswire)
08.09.22	PolarityTE Announces Resignation of Jeff Dyer from its Board of Directors (PR Newswire)
11.08.22	PolarityTE Inc. Q2 Loss Decreases, but misses estimates (RTTNews)
11.08.22	PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update (PR Newswire)
01.08.22	PolarityTE to Report Q2 2022 Financial Results on August 11, 2022 (PR Newswire)
06.06.22	PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules (PR Newswire)
23.05.22	PolarityTE to Attend H.C. Wainwright Global Investment Conference (PR Newswire)
16.05.22	PolarityTE to Effectuate 1-for-25 Reverse Stock Split (PR Newswire)
16.05.22	PolarityTE Inc. Q1 Loss Increases, misses estimates (RTTNews)
16.05.22	PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update (PR Newswire)
13.05.22	PolarityTE: FDA Grants RMAT Designation For SkinTE (RTTNews)
13.05.22	PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE® (PR Newswire)
06.05.22	PolarityTE to Report Q1 2021 Financial Results on May 16, 2022 (PR Newswire)
03.05.22	PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers (PR Newswire)
30.03.22	PolarityTE Reports Fiscal Year 2021 Financial Results and Provides Business Update (PR Newswire)
16.03.22	PolarityTE Announces Closing of $5.0 Million Registered Direct Offering (PR Newswire)
16.03.22	PolarityTE Announces $5.0 Million Registered Direct Offering (PR Newswire)
10.03.22	PolarityTE to Report Fiscal Year 2021 Financial Results on March 30, 2022 (PR Newswire)
17.02.22	PolarityTE Announces Allowance of Fourth U.S. Patent (PR Newswire)
18.01.22	PolarityTE Gets FDA Nod To Commence Phase 3 Study Of SkinTE In Chronic Cutaneous Ulcer Indication (RTTNews)
18.01.22	PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication (PR Newswire)
03.01.22	Pre-market Movers: CELZ, AFI, BLCT, AGE, PTE… (RTTNews)
20.12.21	PolarityTE Says Complete Response Filed To FDA's Clinical Hold Correspondence For SkinTE IND Appn (RTTNews)
20.12.21	PolarityTE Announces Submission of Complete Response to FDA's Clinical Hold Correspondence for SkinTE® Investigational New Drug Application (PR Newswire)
20.11.21	PTE FINAL DEADLINE TUESDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PolarityTE, Inc. Investors to Secure Counsel Before Important November 23 Deadline in Securities Class Action - PTE (PR Newswire)
10.11.21	PolarityTE Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
10.11.21	PolarityTE Reports Third Quarter Financial Results and Provides Business Update (PR Newswire)
06.11.21	ROSEN, A LEADING LAW FIRM, Encourages PolarityTE, Inc. Investors with Losses to Secure Counsel Before Important November 23 Deadline in Securities Class Action - PTE (PR Newswire)
28.10.21	PolarityTE to Report Third Quarter Financial Results on November 10, 2021 (PR Newswire)
24.10.21	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages PolarityTE, Inc. Investors to Secure Counsel Before Important November 23 Deadline in Securities Class Action - PTE (PR Newswire)
07.10.21	PolarityTE Says It Developed Strong Plan To Address Clinical Hold On IND For SkinTE - Quick Facts (RTTNews)
07.10.21	PolarityTE Provides Update on Investigational New Drug Application (PR Newswire)
06.10.21	ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED LAW FIRM, Encourages PolarityTE, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PTE (PR Newswire)
29.09.21	PTE INVESTOR NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages PolarityTE, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PTE (PR Newswire)
02.09.21	PolarityTE Appoints Richard Hague As CEO, Ryan Mathis As Chief Medical Officer - Quick Facts (RTTNews)
24.08.21	PolarityTE Says Study Proposed In IND Application For SkinTE Placed On Clinical Hold - Quick Facts (RTTNews)
12.08.21	PolarityTE Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
28.07.21	PolarityTE : SkinTE Meets Primary Endpoints In Final Analysis From Diabetic Foot Ulcer Trial (RTTNews)
26.07.21	PolarityTE Seeks Authorization To Commence SkinTE Trial On Chronic Cutaneous Ulcers (RTTNews)
13.05.21	EARNINGS SUMMARY: Details of PolarityTE Inc. Q1 Earnings Report (RTTNews)
10.05.21	PolarityTE : Diabetic Foot Ulcer Trial Meets Primary And Secondary Endpoint (RTTNews)
30.03.21	Polarity TE Reports Narrower Net Loss For FY20 (RTTNews)
11.01.21	PolarityTE Forms Strategic Review Committee - Quick Facts (RTTNews)
11.01.21	Pre-market Movers In Healthcare Sector: TRXC, JAGX, ALRN, BNGO, MBRX, APDN… (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sika	220.00	1.29 %	K V
Sonova Hldg	301.40	0.84 %	K V
Alcon	76.76	0.50 %	K V
CieFinRichemont	139.90	0.25 %	K V
Part Grp Hldg	1’333.00	0.23 %	K V
ABB	49.73	-0.48 %	K V
Holcim	88.52	-0.61 %	K V
Roche Hldg G	270.10	-0.63 %	K V
UBS Group	30.11	-0.86 %	K V
Zurich Insur Gr	533.00	-1.30 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Majesco Entertainment Co Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten